Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Standard BioTools Inc. (LAB) had Non-Operating Income/Expense of $7.42M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$21.76M |
|
$-33.46M |
|
$11.13M |
|
$10.63M |
|
$47.46M |
|
$-25.70M |
|
|
Non-Operating Income/Expense |
$7.42M |
$-18.28M |
|
$-18.28M |
|
$-17.67M |
|
$-17.67M |
|
$-33.46M |
|
$-17.67M |
|
$-25.70M |
|
$-22.43M |
|
380.50M |
|
380.50M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$506.04M |
|
$22.68M |
|
$50.93M |
|
$556.97M |
|
$98.02M |
|
$0.30M |
|
$34.41M |
|
$132.43M |
|
$424.54M |
|
$424.54M |
|
$424.54M |
|
381.69M |
|
| Cash Flow Statement Financials | |
$-50.95M |
|
$42.13M |
|
$0.06M |
|
$168.82M |
|
$161.20M |
|
$-7.61M |
|
$15.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.16 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
48.84% |
|
-118.08% |
|
-118.08% |
|
-- |
|
-84.01% |
|
-153.75% |
|
$-57.89M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.46 |
|
1.49 |
|
60.43 |
|
-4.16% |
|
-4.16% |
|
-3.17% |
|
-4.16% |
|
$1.11 |
|
$-0.15 |
|
$-0.13 |
|